
Dementia is a critical issue affecting more than six million older adults in the United States, and the impact on Black and Hispanic communities is particularly severe. Despite its prevalence, cognitive impairments often go unnoticed by healthcare providers, especially in busy primary care settings. Early diagnosis of dementia or mild cognitive impairment (MCI) is crucial for effective treatment and planning, helping to keep older adults safe. However, traditional cognitive tests can be lengthy, expensive, and culturally biased.
In many primary care settings, signs of cognitive impairment are frequently missed, leaving many older adults without the necessary care and support. This issue is even more pronounced among Black and Hispanic populations due to cultural biases in existing cognitive tests and the demanding nature of primary care environments.
To address these disparities, a research team led by Dr. Joe Verghese at the Albert Einstein College of Medicine developed a new cognitive assessment tool called 5-Cog. This innovative tool is designed to be culturally unbiased and can be used by non-healthcare professionals, making it accessible and practical for diverse primary care settings.
RELATED: This Clinical Trial Wants to Help Black Families Dealing with Dementia
The 5-Cog tool consists of three brief tests that assess:
The entire process takes about five minutes, and if the results indicate cognitive problems, the tool automatically updates the patient’s electronic health record. This triggers a set of recommendations to be sent to their healthcare provider, ensuring timely follow-up and intervention.

In a study funded by the National Institutes of Health (NIH), the 5-Cog tool was tested with approximately 1,200 older adults from disadvantaged neighborhoods in Bronx County, New York City. The study population was predominantly Black, Hispanic, or Latino, with a significant portion having low educational attainment. Participants were randomly assigned to take either the 5-Cog test or an unrelated physical test (control group) before their primary care visit.
The results, published in Nature Medicine on June 4, 2024, were promising:
The significance of the 5-Cog tool extends beyond its immediate results. Early detection of dementia allows for better management of the disease, including:
The success of the 5-Cog tool in this study suggests it could transform primary care practices, enabling more older adults to receive timely diagnoses and treatment for cognitive impairments. Further research is ongoing, including a clinical trial to evaluate the tool’s effectiveness in identifying early cognitive changes in older adults who do not report any cognitive concerns. Additionally, the tool will be tested in different populations to ensure its broad applicability and effectiveness.

RELATED: Black Americans Face Tripling Dementia Risk by 2060 – Here’s What You Can Do Now
As a member of the Black community, it is crucial to advocate for the adoption of tools like 5-Cog in your local healthcare settings. Here are some steps you can take:

By subscribing, you consent to receive emails from BlackDoctor.com. You may unsubscribe at any time. Privacy Policy & Terms of Service.